PROVIDER PROFILE · NPI 1235257668

Carlos GadeaM.D.

PRACTICEORLANDO PHYSICIAN SPECIALISTS LLCSee all providers at this practice →

Hematology-OncologyOrlando, FLI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,029

Unique beneficiaries

—

Total services

4,369

Distinct HCPCS

Medicare payment

$203K

Peer benchmark

Total Medicare services vs. 737 Hematology-Oncology providers in FL — above median (cohort median 1,932).

PRESCRIBING · PART D · 2024

Total Rx claims

1,650

Beneficiaries

—

Total drug cost

$6.5M

Distinct drugs

Brand share

45.2%

Top prescribed drugs

Apixaban143 claims

Anastrozole103 claims

Abiraterone Acetate77 claims

Dexamethasone69 claims

Oxycodone Hcl/Acetaminophen66 claims

QUALITY · MIPS · 2024

Final MIPS score

75.0

Quality

0.0

Cost

0.0

Improvement activities

0.0

Promoting interop.

0.0

Payment adjustment

0.00%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$4K

Payment records

143

By payment type

Food and Beverage$3K

Education$350

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (3)

CCN 100006

Hospital

CCN 100007

Hospital

CCN 100030

Hospital

REFERRAL NETWORK

Where Carlos Gadea's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 2 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
BAYSTATE MEDICAL CENTER INC	20	20

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
BAYSTATE MEDICAL CENTER INC	23	29
MEDCARE EMERGENCY HEALTH, INC.	12	19

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history